BNET Industries
Market Cap:$16.3M
Last Fiscal Year Sales:$15.0M
- Public
Co-Author
Sean M O'ConnorContact Information
60-66 Hanover Street
Fitzroy, Victoria 3065
011613-9415-1135
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Recent Events
-
Rosetta Genomics and Genetic Technologies sign distribution agreement
News & Analysis
Filter by
genetic technologies ltd. - All News and Analysis
Just Genes: The Ethics of Genetic Technologies
Just Genes: The Ethics of Genetic Technologies. By Carol Isaacson Barash. 2008. Praeger Publishers. (ISBN 9780313349003). 288 pp. Hardcover. $49.95. When I first saw this book, I scrambled to grab it up. When I teach the unit on applied genetics, I have my students do a project...
In October, Genetic Technologies granted a license to Biosearch Technologies
In October, Genetic Technologies granted a license to Biosearch Technologies for just under AUD1 million ($898,100) to manufacture and distribute oligos, probes and primers for research use.
Biosearch Licenses Genetic Technologies Non-Coding DNA Patents
NOVATO, Calif. -- Biosearch Technologies, Inc. BTI announced today it has been granted a worldwide license to the non-coding DNA patents owned by Genetic Technologies Limited, (NASDAQ GM: GENE, ASX: GTG). BTI becomes the first oligonucleotide synthesis company to take a license from GTG to specifically manufacture and distribute oligos,...
Genetic Technologies Appoints New Chief Executive Officer
MELBOURNE, Australia -- Genetic Technologies Limited (NASDAQ:GENE)(ASX:GTG) is pleased to announce the appointment of Mr. Michael Ohanessian as its new Chief Executive Officer. Most recently, Mr. Ohanessian, aged 43, served for seven years as CEO of Vision Biosystems, a division of former ASX-listed Vision Systems Limited. During this period,...
Genetic Technologies Releases Preliminary Final Report for 2007
MELBOURNE, Australia -- Genetic Technologies Limited (NASDAQ:GENE) (ASX:GTG) is pleased to report it has released its Appendix 4E - Preliminary Final Report, for the year ended 30 June 2007, to the Australian Securities Exchange. The 62-page document will be filed under a Form 6-K with the US Securities and...
Genetic Technologies Achieves Operating Cash Milestone
MELBOURNE, Australia -- Genetic Technologies Limited (NASDAQ:GENE)(ASX:GTG) is pleased to announce that, for the first time in the Company's history, GTG has generated positive net cash flows from operating activities in respect of the financial year ended June 30, 2007. The total cash receipts from operations and interest for...
Genetic Technologies Limited Announces World's First Dog Attack DNA Pack
MELBOURNE, Australia -- Genetic Technologies Limited (NASDAQ:GENE) (ASX:GTG) today launched a new dog attack DNA kit that will allow Australian rangers, livestock owners and police investigators to easily gather canine DNA evidence at dog attack scenes. In what is believed to be a world-first, the City of Port Phillip,...
On February 20, 2007, PatentBridge LLC Terminated Its Relationship with Genetic Technologies Limited
MENLO PARK, Calif. -- On February 20, 2007, PatentBridge LLC terminated its relationship with Genetic Technologies Limited.
UTEK Corporation and Genetic Technologies, Ltd. Announce Technology Acquisition Agreement
TAMPA, Fla. & MELBOURNE, Australia -- UTEK Corporation (AMEX:UTK)(LSE-AIM:UTK), a specialty finance company focused on technology transfer, and Genetic Technologies, Ltd. (Nasdaq:GENE)(ASX:GTG), an Australian life science company, specializing in genetics and genomics, today announced that they have signed a technology acquisition agreement. Under this technology acquisition agreement, UTEK will...
Police seize executives' computers in raid on Genetic Technologies.
Byline: Rebecca Urban Mar 07, 2007 (The Age - ABIX via COMTEX) -- Life sciences group Genetic Technologies has had its Melbourne offices raided by the Australian Federal Police AFP. Computers belonging to a number of senior executives were seized, with the AFP executing...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Sean M O'Connor | Co-Author |
| Fred Bart | Director |
| Organization | Position | Status |
|---|---|---|
| Genetic Technologies, Ltd. | Co-Author | Current |
| Seed IP Law Group Pllc | Specialist | Current |
| The Order of the Coif | Board of Directors | Current |
| American Intellectual Property Law Association | Board of Directors | Current |
| Massachusetts Bar Association | Board of Directors | Current |
| New York State Bar Association | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| GTECH International | Director | Current |
| GTECH International Resources, Ltd. | Director | Current |
| Global Properties Corp | Director | Current |
| Australian Institute of Company Directors | Board of Directors | Current |
| Genetic Technologies, Ltd. | Director | Current |
| Australian Institute of Company Directors | Member | Current |
| Volume | 2,018 |
| Shares Outstanding | 12.4M |
| Market Cap | 16.3M |
| Year High | 4.99 |
| Year Low | 0.80 |
| Earnings Per Share | 0.00 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes

